HIV/AIDS Tuberculosis
Tuberculin skin test detects latent infection during antiretroviral therapy
Published in TB and Outbreaks Week, July 8th, 2003
According to published research from the United States, a "cross-sectional study of 110 individuals examined skin testing for latent tuberculosis infection (LTBI) after the initiation of highly active antiretroviral therapy."
"Skin test reactivity to one or more of four antigens was found in 98 out of 110 subjects (89%)," according to T.L. Fisk and colleagues at Emory University.
Test results showed that tuberculin reactivity was "maximal in those whose CD4 cell counts recovered to greater than or equal to 100...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Infectious Disease Therapy
Oritavancin effective against cephalosporin-resistant pneumococcal meningitis - Tuberculosis Vaccine
Bacille Calmette-Guerin vaccine may improve immunity against other infections - Cancer Therapy
Carpobrotus edulis extract effective against lymphoma, staphylococcal infection - Pulmonary Tuberculosis
Gastric and bronchial lavage useful in borderline cases - SARS
Report says WHO guidelines on SARS should be refined - Staphylococcal Therapy
Novel prodrug shows promise against methicillin-resistant S. aureus - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
